SLC2A2

(redirected from Glucose transporter type 2)
Also found in: Wikipedia.

SLC2A2

A gene on chromosome 3q26.2-q27 that encodes glucose transporter type 2, a plasma membrane glycoprotein of the liver, islet beta cells, intestine and kidney epithelium, which mediates facilitated bidirectional glucose transport.
References in periodicals archive ?
announced today the presentation of new preclinical data showing that antisense drugs potently reduce levels of sodium dependent glucose transporter type 2 (SGLT2), a key component in controlling glucose re-absorption in the kidney and the target of ISIS 388626.
The sodium dependent glucose transporter type 2 (SGLT2) is the primary mechanism responsible for glucose re-absorption in the kidney.
today announced that it has added a new diabetes drug targeting the sodium dependent glucose transporter type 2 (SGLT2) to its development pipeline.
The sodium dependent glucose transporter type 2 (SGLT2) contributes to glucose re-absorption in the kidney.
GlaxoSmithKline (GSK) today announced that it has entered into an exclusive license agreement for Kissei's novel selective inhibitors of the sodium-dependent renal glucose transporter type 2 (SGLT2).

Full browser ?